Ignite Creation Date:
2024-05-05 @ 4:54 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00330044
Status:
COMPLETED
Last Update Posted:
2016-12-02
First Post:
2006-05-24
Brief Title:
Alimta Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer
Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University
Organization:
Thomas Jefferson University
Study Overview
Official Title:
A Phase I Study of Premetrexed Alimta and Carboplatin and Radiation Therapy in Patients With Inoperable Non Small Cell Lung Cancer
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To determine the safety of Alimta when used with chemoradiation in inoperable non small cell lung cancer
Detailed Description:
To determine the maximal tolerated dose MTD and toxicities of Pemetrexed Alimta when administered concurrently with carboplatin and thoracic radiation therapy
To determine qualitatively the occurrence of local tumor responses identified with this regimen
To determine qualitatively the occurrence of local tumor responses identified with this regimen
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005-19 | OTHER | CCRRC | None |